SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
12192003 - LA Times Article (7/20/03) HEALTH Deferred Hope for Dementia Sufferers John McCarthy-7/21/2003
1218Forest’s memantine for treatment of moderate-to-severe dementia of the AlzheimerJohn McCarthy-7/11/2003
1217WASHINGTON (Dow Jones)--Investor Arthur Rock reported holding a 7.39% stake in Nmopgcw-6/23/2003
1216Oops. You're spot-on correct. The trial wasn't against placebo but agaJMarcus-6/19/2003
1215Heck, I knew you weren't shooting the messenger. One problem was that it watom pope-6/19/2003
1214<<The pressure seems a bit overdone to us due to the fact NTII is set to rJMarcus-6/19/2003
121309:35 ET NTII may be oversold on the FRX news Neurobiological Tech (NTII 3.tom pope-6/19/2003
1212Combined Therapy of Memantine and Acetylcholinesterase Inhibitors For The Treatmnigel bates-6/19/2003
1211Desperate Families Embrace Unapproved Alzheimer Drug By GINA KOLATA Charles Bamichael_f_murphy-6/14/2003
1210Michael - thanks! John McCarthyJohn McCarthy-5/12/2003
1209<<< note: i don't know what amitriptyline is >>> amitripMichael P. Michaud-5/12/2003
1208The original Neurontin Trial ... Gabapentin for the symptomatic treatment of paJohn McCarthy-5/10/2003
1207A 1999 Neurontin Trial (very small - but interesting) Arch Intern Med 1999 Sep John McCarthy-5/10/2003
1206Deleted - I was just repeating what John had already posted.tom pope-5/10/2003
1205<<<<<<<< My best guess (FWIW) is that they will put off John McCarthy-5/10/2003
1204<i>We have to watch the NICE decision on Memantine that will be reviewed Dnigel bates-5/10/2003
1203Hi Scott - <<<<<<<<< are we sure that NTII will receJohn McCarthy-5/9/2003
1202Hi John, Assiming approval for Alzheimers but not DN are we sure that NTII willscott mcdowell-5/9/2003
1201Taglich chimes in FWIW... taglichbrothers.comWilliam F. Wager, Jr.-5/8/2003
1200Neurobiological Technologies, Inc. Announces That the Forest Study of Memantine sim1-5/8/2003
1199Contra Costa Times... Equity mover Shares of Neurobiological Technologies Inc.sim1-5/8/2003
1198Thanks, I had begun to suspect that the devil had to be in the royalty details. tom pope-5/7/2003
1197tom - roughly speaking, NTII would earn a 1% royalty on AD Forest Labs sales anJohn McCarthy-5/7/2003
1196I need help here - was that indication so important to NTII's future as to wtom pope-5/7/2003
1195Forest PR: NEW YORK, May 7 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. nigel bates-5/7/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News